Table 2.
Phenotypes of resistance detected among the E. coli isolates recovered from pets.
| Phenotype of resistance | Number of isolates | Percentage of isolates |
|---|---|---|
| CRO | 1 | 2.17 |
| STR | 1 | 2.17 |
| ATM | 1 | 2.17 |
| NALa | 5 | 10.8 |
| KAN + NAL | 1 | 2.17 |
| TET + STR | 1 | 2.17 |
| NAL + TETa | 2 | 4.3 |
| NAL + CRO | 1 | 2.17 |
| AMC + CFZ + AMP | 1 | 2.17 |
| SXT + CFZ + AMP | 1 | 2.17 |
| SXT + CIP + NAL + TETa | 1 | 2.17 |
| STX + NAL + TET + STRa | 1 | 2.17 |
| SXT + TET + STR + AMP + CROa | 1 | 2.17 |
| STX + TET + STR + AMP + CROa | 1 | 2.17 |
| NA + TET + STR + AMP + CROa | 1 | 2.17 |
| STX + CFZ + NAL + TET + AMPa | 1 | 2.17 |
| SXT + SAM + CIP + NAL + TET + AMPa | 1 | 2.17 |
| STX + SAM + CIP + NAL + TET + STR + AMPa | 1 | 2.17 |
| STX + SAM + NAL + TET + AMP + CRO + ATMa | 1 | 2.17 |
| CTX + CFZ + SAM + CPD + CRO + CIP + NAL + AMP + CROb | 1 | 2.17 |
| CAZ + CTX + AMC + CFZ + SAM + CIP + CRO + AMP + ATMb | 1 | 2.17 |
a E. coli developed on the plate with ciprofloxacin; bE. coli developed on the plate with cefotaxime. TET, tetracycline; AMP, ampicillin; STR, streptomycin; STX, sulfamethoxazole-trimethoprim; CRO, ceftriaxone; CFZ, cefazolin; CPD, cefpodoxime; CAZ, ceftazidime; CTX, cefotaxime; ATM, aztreonam; NAL, nalidixic acid; CIP, ciprofloxacin; SAM, ampicillin-sulbactam; AMC, amoxicillin-clavulanic acid; GEN, gentamicin; KAN, kanamycin.